Effects Of Phytoecdysteroids On Skeletal Muscle Contractile Function And Protein Synthesis After Eccentric Muscle Damage by NC DOCKS at Appalachian State University & Rice, Tyler
 
 
 
 
 
 
 
 
EFFECTS OF PHYTOECDYSTEROIDS ON SKELETAL MUSCLE CONTRACTILE 
FUNCTION AND PROTEIN SYNTHESIS AFTER ECCENTRIC MUSCLE DAMAGE 
 
 
 
 
 
 
 
A Thesis  
by 
TYLER THOMAS RICE 
 
 
 
 
 
 
Submitted to the Graduate School 
 at Appalachian State University 
in partial fulfillment of the requirements for the degree of 
MASTER OF SCIENCE 
 
 
 
 
 
 
 
 
 
May 2017 
Department of Health and Exercise Science 
 
 
 
 
  
 
 
 
EFFECTS OF PHYTOECDYSTEROIDS ON SKELETAL MUSCLE CONTRACTILE 
FUNCTION AND PROTEIN SYNTHESIS AFTER ECCENTRIC MUSCLE DAMAGE 
 
 
 
 
 
A Thesis  
by 
TYLER THOMAS RICE 
May 2017 
 
 
 
 
 
APPROVED BY:  
  
 
        
R. Andrew Shanely, Ph.D. 
Chairperson, Thesis Committee 
 
 
        
Kevin A. Zwetsloot, Ph.D. 
Member, Thesis Committee 
 
 
        
Alan C. Utter, Ph.D., M.P.H.  
Member, Thesis Committee 
 
 
        
Kelly J. Cole, Ph.D. 
Chairperson, Department of Health and Exercise Science 
 
 
        
Max C. Poole, Ph.D. 
Dean, Cratis D. Williams School of Graduate Studies 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by Tyler Thomas Rice 2017 
All Rights Reserved 
 
 
 iv 
 
 
 
 
 
 
Abstract 
 
EFFECTS OF PHYTOECDYSTEROIDS ON SKELETAL MUSCLE CONTRACTILE 
FUNCTION AND PROTEIN SYNTHESIS AFTER ECCENTRIC MUSCLE DAMAGE 
 
Tyler Thomas Rice 
B.S., Slippery Rock University 
M.S., Appalachian State University 
 
Chairperson:  R. Andrew Shanely, Ph.D. 
 
 
 Our preliminary data demonstrate that phytoecdysteroids, such as 20-
hydroxyecdysone (20E), have no effect on muscle hypertrophy in young sedentary mice. Yet 
in old sedentary mice we have shown an increase in protein synthesis signaling and muscle 
fiber size. These divergent observations suggest that phytoecdysteroids in young skeletal 
muscle may require a stimulus to be effective. The objective of this study was to determine if 
20E enhances recovery of maximal tetanic torque production and additively stimulates 
Akt/mTOR signaling after 150 injurious eccentric skeletal muscle contractions (EC). Male 
C57BL6 mice (3-6 mo-old) were randomly assigned to either the EC + placebo or EC + 20E 
group. In vivo isometric contractions (Aurora Scientific, 1300A) were performed to obtain 
optimal electrode placement and voltage. Following electrode placement, in vivo torque 
frequency was assessed, 150 eccentric contractions were performed and in vivo torque 
frequency was administrated to assess torque production immediately post-injury to the 
anterior crural skeletal muscles. Upon completion of the EC and torque frequencies, the mice 
received an oral gavage of either 20E (50 mg·kg
-1 
BW) in liquid diet (BioServ AIN-76) or 
 v 
placebo (liquid diet only) and allowed to recover. Mice were gavaged daily for 2 or 6 days.  
On day 3 or 7, post-injury torque frequency was assessed and skeletal muscles were 
harvested and prepared for assessment of Akt/mTOR signaling via Western blot analysis. No 
significant differences in recovery of torque production within groups were observed at any 
time point or treatment. Furthermore, no significant differences were found in activation of 
Akt, 4E-BP1, or rpS6 intracellular signaling between treatments. These data suggest that 20E 
does not additively stimulate an increase of protein synthesis and enhance recovery of torque 
production after eccentric contraction injury. Additional research may be warranted on the 
dosage amount that may additively increase protein synthesis and torque production after 
eccentric contraction injury.  
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Foreword 
 
 
 This thesis will be submitted to a journal within the American Physiological Society. 
This thesis is formatted according to the style for the American Physiological Society. 
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Chapter 1: Introduction 
Skeletal muscle is the most abundant tissue in the human body by mass and is 
susceptible to multiple types of injuries, for example, injury from eccentric contractions. 
Eccentric contractions occur when a strain is put on the muscle by which opposite tensile 
forces are present at the same time (11).  The cost of injuries due to eccentric damage within 
hospitals is difficult to determine since hospitalization is typically not required. Without 
correct medical care a significant skeletal muscle injury can cause incomplete functional 
recovery and possibly reinjury (50). Currently there is no ideal immediate treatment for 
eccentric muscle injury but the most advised treatment is the use of the RICE (rest, ice, 
compress, and elevate) method (41).  
Muscle injuries can lead to disrupted connective tissues, myofiber necrosis, 
hematoma, and inflammation. This disruption in muscle homeostasis can cause a loss of 
skeletal muscle strength as well as atrophying of the muscle leading to pain with movement, 
decreased range of motion, or general soreness (60). Few studies have sought ways to 
remedy muscle injuries. Nonsteroidal medications are typically used to decrease 
inflammation in injured skeletal muscle (55). Alternative ways of treating muscle injuries 
using anabolic agents as well as catabolic agents have been examined. Acutely, catabolic 
agents return force-generating capacity in muscles after injury (10). Chronically, anabolic 
agents recover force-generating capacity and morphology in muscle after injury, indicating 
that anabolic agents are worth further study on recovery of force-generating capacity and 
morphology after a muscle injury (10).  
Phytoecdysteroids are being investigated to determine the anabolic effects on skeletal 
muscle. Phytoecdysteroids, which are derivatives of an arthropod steroid hormone called 
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ecdysteroids, are structurally related to cholesterol-based mammalian steroid hormones 
without the harmful side effects associated with anabolic steroids. Phytoecdysteroids work 
through a cascade of cellular mechanisms involving calcium flux into the cell and eventually 
cause activation of Akt (Protein Kinase B). Thus protein synthesis is maybe increased 
through supplementation with the phytoecdysteroids (32). Ecdysteroids increase protein 
synthesis in culture of muscle cells and increase force-generating capacity in rats (24, 32). 
The ecdysteroid 20-Hydroxyecdysone (20E) has also been shown to increase muscle fiber 
size (64). However, no studies have been conducted to determine if phytoecdysteroids will 
enhance the recovery of muscle function and morphology after eccentric contraction muscle 
injury. Therefore, the purpose of this study was to determine the degree to which 
phytoecdysteroids (1) enhance recovery of maximal tetanic torque production and (2) 
additively increase protein synthesis after a bout of eccentric contraction muscle injury. I 
hypothesized that phytoecdysteroids would (1) accelerate the rate of recovery of muscle 
maximal tetanic torque production and (2) additively increase the rate of protein synthesis 
after an eccentric contraction muscle injury to the anterior crural muscles compared to 
injured mice not receiving phytoecdysteroid treatment.  
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Chapter 2: Review of Literature 
 The purpose of this literature review is to provide background knowledge on how 
phytoecdysteroids function in the body of mammals and their ability to promote muscle 
growth through possible anabolic mechanisms. Furthermore, it is to provide knowledge on 
how eccentric contraction muscle injury models are utilized to simulate injuries and can be 
used in studies that are interested in investigating regeneration of skeletal muscle function. 
While studies have investigated these two ideas separately, there is a lack of knowledge on 
how phytoecdysteroids would mediate the muscle healing process after a muscle injury.  
Phytoecdysteroids 
Structure and Function 
 
  Phytoecdysteroids are plant derived analogues of ecdysteroids which are insect 
molting hormones. Structurally, phytoecdysteroids are cholesterol derived steroid hormones 
and are distinctly different than mammalian steroid hormones. Phytoecdysteroids are 
considered ketosteroids that have long carbon side chains. Phytoecdysteroids comprise a 
class of steroids with a polyhydroxylated cyclopentano perhydrophenanthrene ring system 
and are typically comprised of a 27-29 carbon skeleton. These polyhydroxylated ketosteroids 
are primarily produced by insects and plants (7, 31, 32, 39). The purpose of ecdysteroids that 
are produced within insects is to regulate metamorphosis, and several other pivotal life-cycle 
events. In plants, phytoecdysteroids serve as a chemical defense against insects or soil 
nematodes by disrupting the hormonal balance and molting processes. This chemical defense 
causes development disruption and can even cause eventual death in insects and soil 
nematodes (12, 45). 
The most commonly studied phytoecdysteroid that has been studied is 20-
Hydroxyecdysone (20E). 20E is reported to be safe when consumed by mammals due to its 
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low acute toxicity (25, 39). 20E is considered to exhibit very low acute toxicity in mice and 
rabbits when administered orally (7, 52). Phytoecdysteroid extracts (such as Ajuga 
turkestanica extract) have not shown any adverse side effects with exogenous 
supplementation such as atrophy of the testes or enlargement of tissues other than skeletal 
muscle (7, 39). A recent study has confirmed that 20E does not affect organ  (heart, liver, 
spleen, kidneys, and testes) wet mass compared to body mass (47). Low acute toxicity in 
mammals indicates that phytoecdysteroids might not cause side effects or negative health 
risks compared to exogenous testosterone or estrogen supplementation. While bioavailable in 
the blood, low levels of the phytoecdysteroid 20E does not have any acute toxicity effects, 
but if administered over the LD50 (Lethal dose able to kill 50% of the exposed population) of 
6g/kg it can cause high levels of toxicity possibly leading to eventual death in mammals (7, 
26).   
Sources 
 Phytoecdysteroids have been measured in over 100 terrestrial plant families that 
include plants such as ferns, gymnosperm and angiosperms as well as being found in both 
annual and perennial plants. Phytoecdysteroids have been found in plant species such as 
Ajuga, Serratula, Silene and Leuzea (7, 25). Some commonly eaten foods that contain 
phytoecdysteroids in noticeable amounts are spinach, quinoa, yams, and chestnuts (8, 33, 58). 
These have variable amounts of phytoecdysteroids, for example, quinoa has 4-12 times more 
20E by dry weight when compared to spinach leaves (46). Very little of the world’s plant life 
has been investigated to determine exactly how many and what type of plants actually 
contain phytoecdysteroids.  
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Protein Synthesis and Signaling Pathways 
 Phytoecdysteroids, including 20E, have profound impacts on metabolic function in 
mammals, specifically 20E. Within C57BL/6 mice the triceps brachii muscle mass increased 
after continuous infusion of 20E for five days, however the muscle mass of several other 
muscles were unchanged (20). Cheng et al. (21) also measured other physiological 
parameters but didn’t observe a significant change; suggesting that 20E has mild local 
anabolic effects. Other studies have found that 20E may actually have potent anabolic 
properties. Treatment with 20E in rat hind limb muscles increases muscle cross sectional area 
and affects muscles differently (64). Toth et al. (64) suggest that 20E works in a muscle 
specific fashion rather than a muscle fiber dependent manner.  
 In C2C12 myotubes protein synthesis increased up to 120% compared to the control 
group starting at two hours, peaked at eight hours, and remained significant for the remainder 
of the 24 hour experiment (32). Another study confirmed the findings that 20E 
supplementation increased protein synthesis in C2C12 in a dose dependent manner (21).   
 Other metabolic functions due to supplementation of phytoecdysteroids have been 
measured. For example, phytoecdysteroids can have effects on lipid metabolism by causing 
hypocholesterolamic effects (26). This could be attributed to the conversion of cholesterol 
into bile acids (26). Also, phytoecdysteroids may decrease hyperglycemia which otherwise 
would be induced by administration of glucagon or by destruction of the pancreatic islet β-
cells (26). The same study also suggests that phytoecdysteroids have effects on other organs, 
for example, liver, kidneys, skin and brain.  The liver is caused to secrete more bile after 
supplementation with phytoecdysteroids. 20E supplementation can restore glomerular 
filtration rate (26). Phytoecdysteroids have also been reported to accelerate the healing 
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process of small wounds or burns on the skin (26). Further 20E supplementation protects 
neurons within the CNS against deleterious effects of various drugs (26). Overall, the above 
information suggests that there are possible benefits of supplementing with 
phytoecdysteroids in mammals with very few, if any, side effects.  
Phytoecdysteroids Effects on Skeletal Muscle 
 Recent studies indicate that phytoecdysteroids, unlike mammalian steroids, utilize an 
androgen independent receptor (7, 32). These studies suggest that 20E works through a G-
protein coupled receptor (31). This receptor when activated then activates phospholipase C 
(PLC). PLC breaks down phosphoinisotol 3-phosphate (PIP3) into inositol 3-phosphate 
(IP3). IP3 then travels to the sarcoplasmic reticulum (SR) and binds to the IP3 receptor 
(IP3R).  Once IP3R is activated by IP3, intracellular calcium is released from the SR into the 
cytoplasm. The increase in intracellular calcium allows for activation of 
phosphatidylinositol-3-phosphate kinase (PI3K). PI3K produces the earlier mentioned PIP3. 
PIP3 then activates phosphatidylinositol dependent kinase (PDK1) as well as Akt (Protein 
Kinase B). Akt is a phosphorylated version of serine/threonine-specific protein kinases which 
is activated or phosphorylated by PI3K. Akt then phosphorylates and activates mammalian 
target of rapamycin (mTOR), and subsequently increases protein synthesis in skeletal muscle 
tissue. Akt can also decrease protein degradation through phosphorylation of Forkhead Box-
O (FOXO) protein. Once FOXO is phosphorylated it is unable to translocate to the nucleus of 
the cell and increase the expression of key degradation proteins, Murf-1 and Mafbx. 
Ultimately, phytoecdysteroids in this context would increase protein synthesis (31, 32) and 
perhaps decrease protein degradation. Gorelick-Feldman et al. (32) observed an increased 
strength in rat grip strength after supplementation of 20E (50 mg/kg BW) for 28 days, 
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suggesting that 20E does indeed activate Akt phosphorylation. Another study by Lawrence 
(47)  observed that when older mice (20·months old) are supplemented with 20E (50 mg/kg 
BW) for 28 days there was an increase in muscle fiber cross sectional area of the plantaris 
and triceps brachii.  According to the previous studies one would think that supplementation 
of 20E would increase cross sectional area of muscle due to the increased activity on Akt 
phosphorylation at any time point. On the contrary, a recent study has shown that 20E does 
not acutely activate Akt phosphorylation or mTOR signaling in young healthy rats (1). This 
study suggests that a loading phase of 20E may be required to have any effects on Akt 
phosphorylation or the mTOR pathway. The combination of aforementioned studies suggests 
that phytoecdysteroids work on activation of Akt and the mTOR pathway, but how 
effectively they work remains unknown.  
 Concentrated extracts of phytoecdysteroids from plants such as Ajuga turkestanica  
have other beneficial cellular functions within aged skeletal muscle thus possibly decreasing 
the onset of sarcopenia (4). During sarcopenia, skeletal muscles are unable to completely 
repair themselves through the regeneration process (3, 6). During the skeletal muscle repair 
process Notch and Wnt signaling are important for satellite cell activity and regeneration (14, 
65). Studies have demonstrated that C57BL/6 mice exposed to phytoecdysteroids specifically 
20E, exhibited an increase in components of both Notch and Wnt signaling pathways in the 
triceps brachii muscle in aged mice. The increase of these pathways might help aged skeletal 
muscle prepare for regeneration after muscle damage (4). To be able to improve the quality 
of living with better muscle function it is of importance in the elderly. Although much of the 
research to this point demonstrates the anabolic properties of phytoecdysteroids the effects 
they have on different aspects of muscle regeneration are still unknown.   
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Role in Inflammation 
 Phytoecdysteroids have many effects in mammals as stated above; some may have 
other important effects in inflammation. Phytoecdysteroids have been shown to have potent 
anti-inflammatory properties when studied with pro-inflammatory factors (51, 61). If, or 
when, skeletal muscle becomes damaged inflammation proceeds due to one of many pro-
inflammatory agents, such as 12-O-tetradecanoylphorbol-13-acetate (TPA) (70). Sun and 
Yasukawa have shown that eight ecdysteroids have inhibitory effects against TPA which 
produced the inflammation. Another pro-inflammatory agent, carrageenan, has been shown 
to increase inflammation with in skeletal muscle thus decreasing muscular strength (53). 
Ochieng et al. (51) has shown that some phytoecdysteroids inhibit the effects of carrageenan 
induced inflammation on skeletal muscle. Specifically the Ajuga species of plants are said to 
have anti-inflammatory effects (39), but in what aspect is still unknown. These studies 
suggest that different phytoecdysteroids have anti-inflammatory properties to counteract pro-
inflammatory agents within the muscle after damage.  
Muscle Damage 
Eccentric Contraction 
 One of the most common types of muscle damage is a strain or eccentric muscle 
damage typically caused when opposite tensile forces are present at the same time on the 
muscle causing damage (11). A muscle injury causes muscle soreness, movement with pain, 
and a limited range of motion. Many studies have used a non-invasive approach in studying 
muscle damage via strain or an eccentric muscle contraction model. These models are 
typically used to determine possible methods of treatment from a muscle injury. Such studies 
have examined methods such as immobilization, RICE, exercise, therapeutic ultrasound, 
nonsteroidal anti-inflammatory medications, and hyperbaric oxygen therapy (41).  
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 A common model for studying eccentric muscle injury in mice is to induce injury via 
eccentric contractions (22, 23, 30, 68). In this model a mouse is placed on a heated platform 
to minimize heat loss, and then the left foot is attached to a foot pedal which is attached to a 
force transducer. Sterile needle electrodes are placed through the skin on either side of the 
common peroneal nerve, stimulation of the nerve then causes contraction of the anterior 
crural muscles. Electrode placement and optimal voltage are confirmed via 5-15 isometric 
contractions at 300 Hz with a 200-ms train duration and 0.5-ms pulses. Ultimately, injury is 
induced via 150 eccentric contractions. The left foot of the mouse is passively dorsiflexed to 
20° and then while the muscles were stimulated, the foot was plantar flexed 40° at 2000°·s
-1
.  
The anterior crural muscles are stimulated eccentrically for 20-ms trains, 0.5-ms pulses, at 
300 Hz. An isometric contraction precedes the eccentric contraction which lasts 100-ms, 0.5-
ms pulses, at 300 Hz. A 10-s pause is placed between each eccentric contraction and every 
tenth eccentric contraction torque is recorded (22, 23, 30, 68).  
Inflammatory Response and Muscle Healing 
 After muscle injury the immune system is activated causing inflammation. There are 
three phases after muscle injuries. First is the destruction phase which is characterized by 
damage to the muscle structure and extensive damage to the vasculature within the muscle. 
Due to the damage of the vasculature, the inflammation response by the immune system is 
typically followed by cell death of the damaged muscle fibers. With an injury that only 
causes moderate damage, the vasculature within the muscle is typically undisrupted. The 
result of undisrupted vasculature allows the arterioles within the muscle to vasodilate 
allowing the inflammation response to commence. One result of the vasodilation allows for 
an increase in numbers of phagocytic leucocytes and levels of plasma proteins which are both 
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important for the inflammation response (62). The second phase is the repair phase, 
characterized by production of scar tissue and regeneration of vasculature (16).  This phase 
works mostly through phagocytosis which will clear the necrotic tissue. Neutrophils have a 
very important function in providing phagocytic functions by clearing necrotic tissue as well 
after damage (63). They also increase the inflammation response by releasing pro-
inflammatory cytokines. Although neutrophils work in clearing the necrotic tissue, they may 
be damaging the tissue even further (36, 37, 62). Phagocytic macrophages also help in the 
clearing of necrotic tissue and repairing of the muscle fibers. The same macrophages appear 
later in the process after the decrease in neutrophils. These macrophages trigger growth 
factors and cytokines to help with muscle healing (2, 49). The third and final phase is the 
remodeling phase, which is characterized by the formation and organization of newly formed 
muscle fibers as well as a decreased lesion size. This phase also constitutes an improvement 
in muscle function as well as angiogenesis within the muscle. Fibroblasts play a pivotal role 
in the regeneration of muscle tissue by secreting extracellular proteins such as growth factors 
(59, 60).   
 In a muscle healing study by Khattack et al. (42) after an injury, it was observed that 
in the mobilization (allowed to move freely) group there was an increase in myotubel 
formation as well as a decrease in the inflammation response that may result in a better 
healing response (42). These data suggests that if the inflammation response is decreased by 
mobilizing the limb, then the muscle will heal quicker than if it was immobilized (placed in a 
cast). Other studies examined muscle healing through supplementation of suramin two weeks 
after contusion and strain injuries (19, 50). Suramin is an antiparasitic and antineoplastic 
agent which has been shown to enhance muscle regeneration after strain and laceration 
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injuries (18, 19). Two weeks after muscle contusion with the supplementation of suramin 
showed an increase in regenerative muscle fibers. Suramin injection can also increase 
strength and muscle function after a muscle injury (19). Chan et. al (19), also showed an 
increased number of regenerating myofibers compared to control groups after strain injury. 
Furthermore, suramin also recovered fast-twitch strength to control values with injection of 
5.0 mg suramin (19). A study which examined the effects of a nonsteroidal anti-
inflammatory drug (NSAID), flurbiprofen, showed an increases in maximal torque recovery 
at three and seven days but a decline in torque at 28 days when treated with the NSAID (27). 
These authors suggest that with flurbiprofen administration the inflammation process is 
delayed and ultimately causes secondary muscle damage which would be an explanation for 
the late decline in torque (27).   Another study exhibited that supplementation of 
proanthocyanidolic oligomers (PCO) blunted the neutrophil infiltration response while 
allowing earlier macrophage infiltration into the tissue (43). Kruger and Smith (43) saw 
quickened muscle regeneration due to earlier recruitment of activated satellite cells and 
modulation of the immune system for anti-inflammatory status when supplementing short 
term with PCO. This may provide a natural alternative for anti-inflammatory treatments but 
more research is warranted on the cellular mechanisms in how PCO affects muscle healing. 
These studies suggest that an intervention with medication or natural agents can increase the 
healing process and recover force-generating capabilities.  
Contractile Function: In Vivo Contractile Function After Injury 
 After a muscle injury the muscle may not be able to move without pain, limited range 
of motion, or just muscle soreness (60). After an eccentric muscle contraction induced injury, 
the immediate post-injury in vivo maximal tetanic torque production has been reported to 
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decrease by 55% compared to the pre-injury value (68). Furthermore, at 3 days post-injury, 
maximal tetanic torque was attenuated by about 50% compared to pre-injury. At day 14, 
maximal tetanic torque was attenuated by 10% and maximal tetanic torque was fully 
recovered 21 days after injury (68). Another study measured a 50% decrease of maximal 
tetanic torque production immediately after injury (23). A decrease of about 53% has also 
been reported immediately post-injury in maximal tetanic torque production, and the values 
were still attenuated at 14 days post-injury (22). These studies suggest there is an immediate 
and prolonged decrease in maximal tetanic torque production after eccentric contraction 
induced skeletal muscle damage to the anterior crural muscles.   
Protein Synthesis After a Mechanical Stimulus  
 Recent research has shown a mechanical stimulus of skeletal muscle such as 
overload, concentric or eccentric contractions increase protein synthesis via an activation of 
mTOR and other downstream intracellular signaling mediators (13, 71). Firstly, mTOR is 
activated by Akt via phosphorylation of tuberous sclerosis complex-2 (Tsc2) thus activating 
mTOR (38). A more recent study has suggested that after eccentric contractions mTOR is 
stimulated via Tsc2 (40). The mTOR pathway has also been reported to be activated after 
high frequency stimulation of rat muscles (13). Activation of mTOR in turn stimulates p70s6 
kinase (p70s6k) (15). In high frequency lengthening contractions p70s6k is phosphorylated 
(5). This event ultimately leads to inhibition of eukaryotic initiation factor 4 binding protein 
(4E-BP1) which is a negative regulator of protein synthesis (34, 54, 71). The phosphorylation 
of both p70s6k and 4E-BP1 lead to an increased rate of translation initiation for protein 
synthesis (44).  It is thought that p70s6k leads to phosphorylation of ribosomal protein S6 
(rpS6) as well, which leads to an increase in protein synthesis after resistance exercise (17, 
 
 
 
13 
66). Phosphorylation of rpS6 has been used as an indirect indicator of mTOR activation but 
the exact role rpS6 plays in regulation of protein synthesis is still to be determined fully (29).  
 Studies have investigated the effects of eccentric contraction induced injuries on 
protein synthesis rates after injury. Lowe et al. (48) reported that after eccentric muscle 
damage protein synthesis rates begin to increase 2 days post injury (48). At three and five 
days post-injury protein synthesis rates were increased by about 30% and 40% respectively 
(48). Furthermore, after high frequency eccentric contractions between 12-17 hours protein 
synthesis rates of the TA was increased 41% (69). Wong and Booth (69) also measured a 52-
65% increase in protein synthesis at 36-41 hours post eccentric exercise. These studies 
suggest that increased protein synthesis is required for muscle regeneration as well as a 
recovery of torque and force production after injury (9, 48, 57, 69).  
Anabolic Agent Effects on Healing 
 Anabolic agents such as testosterone cause an increase in muscle mass and strength 
when supplemented in humans. When it comes to the effects of anabolic agents on healing 
after a muscle injury very little research has been conducted. One of the few studies with 
anabolic steroids and corticosteroids observed several important factors (10). First, anabolic 
steroids did not increase muscle healing in respect to twitch and tetanic force production 
acutely (10). However, there was a trend for chronic anabolic steroid treatment to increase 
twitch and tetanic force production. Corticosteroids acutely reduce the inflammation 
response by decreasing the amount of inflammatory cells (10). Acute corticosteroid treatment 
did increase acute twitch and tetanic force when compared to the anabolic steroid and control 
groups (10). Chronically, corticosteroid treatment does not improve healing from injury (10). 
This study observed that corticosteroids caused atrophy within the muscle as the time frame 
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was prolonged (10). More research is warranted on the effects of different doses of 
corticosteroids to determine how atrophy is affecting the healing process (10). However, 
unlike typical anabolic steroids, 20E has been reported to utilize a non-androgenic receptor 
and still increase growth during the regeneration process (64). 
 Many studies have utilized the eccentric contraction model to simulate injury for 
study of the muscle healing process. Muscle injury results in the loss of strength, functional 
movement and possibly muscle mass. Phytoecdysteroids have been shown to increase protein 
synthesis and have possible anabolic properties. Very few studies have examined the effects 
of anabolic agents on muscle damage that was induced by an eccentric muscle contraction. 
This warrants further research to determine the possible healing effects of phytoecdysteroids 
on an eccentric muscle contraction induced injury.  
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Chapter 3: Methods 
Animals 
 Male C57BL/6 mice (n = 32) 3-to 6-months of age were randomly assigned to one of 
four groups (n = 8/group), see Figure 1. The mice in all groups underwent an eccentric 
muscle contraction injury protocol and the muscle repair process was investigated with or 
without phytoecdysteroid supplementation. The mice were kept on a normal 12h: 12h light-
dark cycle, food, and water were provided ad libitum.  
 
 
Figure 1. Protocol schematic for experimental design. *Injury – indicates when mice were 
injured. 
 
 
Experimental Design 
  Mice underwent the eccentric muscle contraction injury protocol to the anterior crural 
muscles after which they were supplemented with 50mg·kg
-1
 body weight (BW) (32, 47)
 
of 
20E or placebo up to 7 days. The day of injury, an in vivo torque-frequency protocol was 
utilized before and after injury to assess the submaximal to maximal torque response. The 
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injury was induced via 150 eccentric skeletal muscle contractions. The day of euthanasia, the 
torque-frequency protocol was administrated.  Following contractile function measurements, 
animals were euthanized and skeletal muscle was dissected, weighed, and stored at -80° C 
until further analysis of intracellular signaling and protein synthesis via Western blot 
analysis. All experiments and procedures were approved (12/12/2016) by the Appalachian 
State University Institutional Animal Care and Use Committee (#17-09). 
In Vivo Torque-Frequency and Eccentric Muscle Damage 
 A commonly used model of in vivo contractile function and eccentric muscle damage 
was utilized for this experiment, as previously described by Corona et al. (22). Mice were 
weighed prior to being anesthetized via inhalation of 4% isoflurane with 800 mL/min oxygen 
(O2) and maintained at 2% inhaled isoflurane with 500 mL/min O2 output throughout the 
duration of the experiment. Once anesthetized the hair on both hind limbs was removed with 
a depilation cream, thus allowing the anterior crural muscles to be better visualized through 
the skin. The mice were then placed on a heated platform to maintain body temperature and 
the left foot was secured to the foot pedal connected to the computer controlled servomotor 
(Model 305B-LR; Aurora Scientific, Richmond Hill, Ontario, Canada). Sterilized electrode 
needles were placed percutaneous for stimulation of the left common peroneal nerve. 
Optimal electrode placement was determined using 5-15 isometric contractions (200-ms 
train, 0.1-ms pulses at 300 Hz). An in vivo torque-frequency protocol was utilized to assess 
contractile function of the anterior crural muscles at increasing frequencies (1-300 Hz) with 2 
minutes rest in between contractions before injury, 5 minutes after injury, and either 3 or 7 
days post-injury. Injury to the anterior crural muscles was induced via 150 eccentric muscle 
contractions (300 Hz, 120-ms train of 0.1-ms pulses with 38° angular movement at 
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2000°·sec
-1
). Peak eccentric torque was measured at every tenth eccentric contraction. The 
right leg was then secured to the foot pedal, optimal electrode placement was found, and the 
eccentric muscle damage protocol was administered. The mice were then returned to 
individual cages and allowed to recover. At either 3 or 7 days post-injury, the mice were 
anesthetized as described above and an in vivo torque-frequency protocol was administered 
to the left hind limb to assess contractile function of the anterior crural muscles. After 
contractile function assessment the mice were injected interperitionel with puromycin (0.040 
µmol·g
-1
 BM) 30 minutes prior to euthanasia for assessment of protein synthesis via Western 
blot analysis. Mice were euthanized via cervical dislocation while under anesthesia and 
confirmed dead via removal of the heart before dissection of skeletal muscles. The anterior 
crural skeletal muscles (tibialis anterior and extensor digatorum longus) were harvested from 
both hind limbs and wet weights were measured. The left hind limb skeletal muscles were 
either frozen in liquid nitrogen (N2) cooled isopentane and the right hind limb skeletal 
muscles were snap frozen in N2 and stored in a -80°C freezer until further analysis.  
Phytoecdysteroid Supplementation 
 After receiving the eccentric muscle injury and after recovery from the anesthetic on 
day zero, the mice were supplemented phytoecdysteroid 20-hydroxyecdysone (20E) 
(50mg·kg
-1 
BW or 0 mg·kg
-1
 BW); Bosche Scientific, (E6425-HE; New Brunswick, NJ, 
USA). The dose of 20E or placebo was delivered via a liquid diet supplement (Liquid Diet; 
cat #F1268 BioServ, Flemington, NJ). The liquid diet is a nutritionally complete diet that 
contains 17.5% protein; 5.4% fat; 4.8% fiber; and 67.7% carbohydrate. The previous day’s 
BW was used to calculate the appropriate dosage of 20E mixed with the liquid diet 
supplement. The required amount of 20E was dissolved in warm tap water and placed into a 
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single serving of the liquid diet (placebo). The liquid diet with or without 20E was served to 
the mice via gavage which was calculated as 1% of the BW of the mice.  
Western Blot Analysis 
 Right tibialis anterior and extensor digitorum longus skeletal muscles were 
homogenized, as previously done in our lab (47), on ice in 0.3 ml homogenization buffer 
containing 150.0 mM NaCl, 1.0% Triton-X, 0.5% sodium deoxycholate, 10 mM Tris-HCl, 
pH 7.4 with protease and phosphatase inhibitor cocktails (Sigma Aldrich; St. Louis, MO, 
USA). After homogenization, samples were cleared by centrifugation of the homogenate at 
14,000 x g for 5 minutes @ 4°C. The supernatant was removed and protein concentration 
was assessed via BCA protein assay (Pierce; Thermo Fisher Scientific, Inc.; Rockford, IL, 
USA). Total protein (30 µg) was prepared using a Laemmli buffer and subjected to 
electrophoresis separation by SDS-PAGE on 4-15% TGX-stain free acrylamide gels (Catalog 
# 5678084; Bio-Rad; Hercules, CA, USA) as previously described (35). After completion of 
the electrophoresis the proteins were transferred to a polyviylidene difluoride (PVDF) 
membrane (Millipore; Bradford, MA, USA) and imaged under ultraviolet light to ensure 
equal loading and transferring of proteins, as well as to quantitate total protein for 
normalization. Membranes were blocked using 5% nonfat dry milk in wash buffer [1X Tris-
buffered saline (TBS) with 0.1% Tween20] for one hour at room temperature. Following 
blocking, the membranes were washed two times and immediately incubated sequentially 
with the following primary antibodies overnight @ 4°C: anti-puromycin [MillporeSigma; 
Billerica, MA, USA – MABE343, clone 12D10; 1:5000 in 1% bovine serum albumin 
(BSA)], as well as phosphorylated Akt
Ser473
 (Cell Signaling; Danver, MA, USA – 9271); 
phosphorylated 4E-BP1
Thr37/46
 (Cell Signaling – 2855); and phosphorylated rpS6
Ser235/236
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(Cell Signaling – 2211),  (all signaling antibodies = 1:1000 in 5% BSA). After primary 
antibody incubation, membranes were washed 5 times for 5 minutes each in wash buffer and 
then incubated with secondary antibodies for 1 hour at room temperature (1:50,000 for 
puromycin and 1:20,000 for signaling antibodies).  Next, the membranes were washed 5 
times for 5 minutes each in wash buffer. Membranes were exposed to SuperSignal West 
Dura ECL chemiluinescent detection HRP reagents (Pierce; Thermo Fisher Scientific, Inc.; 
Rockford, IL, USA) mixed 1:1 for 5 minutes. Membranes were then imaged and 
densitometry analyzed using the ChemiDoc XRS+ molecular imaging system and analysis 
software (BioRad).  
Data Acquisition and Analysis 
The muscle lever system, stimulator and force transducer was connected to a signal 
interface (Model 610A, Aurora Scientific, Aurora, ON, Canada) that sent the analog signal to 
an analog to digital converter card (Model PCI-6221, National Instruments, Austin, TX, 
USA) on a computer with Dynamic Muscle Control software (Aurora Scientific, Aurora, ON, 
Canada). The force output data was analyzed utilizing the Dynamic Muscle Analysis 
software (Aurora Scientific, Aurora, ON, Canada).  
Statistics 
 All values are expressed as mean ± SE, and statistical significance was set at p < 0.05. 
A Bonferroni correction was to determine statistical significance and was set at p < 0.00625. 
A univariate test was used to determine differences in protein synthesis rates, 
phosphorylation of: Akt, 4E-BP1, and rpS6, between the 20E and the placebo group. A three-
way ANOVA with repeated measures was used to evaluate the recovery of muscle torque-
generating capacity. Treatment group, harvest time post-injury, and stimulation frequency 
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constituted the three factors. A three-way interaction was assessed for differences within 
groups (group x harvest day x time). This was utilized for determining differences in the 
recovery of torque generating capacity of the muscles. A least significant difference post-hoc 
analysis was used to determine differences within/between groups.  Data was analyzed using 
SPSS 24.0 for windows (SPSS Inc., Chicago, IL, USA).  
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Chapter 4: Results 
In Vivo Contractile Function 
Isometric twitch (1 Hz) torque production is a single submaximal stimulation and is 
reported as (mN/kg BW). The pre-isometric twitch torque was compared to the post-
isometric twitch torque, this was also done at other specific frequencies as well (i.e., 20, 40, 
200 Hz). Comparing the twitch isometric torque of the 3-day placebo group before injury to 
post-injury there was a significant difference in torque production (Table 1). All the other 
groups at the other frequencies were significantly different from pre-to post-injury, with the 
pre-injury being significantly greater than post (Table 1).  
Twitch torque is the same between both 3-day placebo and 20E groups before 
induction of eccentric muscle injury (Table 2).  After the eccentric muscle injury protocol, 
the isometric twitch torque production was the same for placebo and 20E groups immediately 
post-injury (Table 2). At 3 days post-injury there was not a difference in torque generating 
capacity (Table 2). Likewise, with the 7-day placebo and 20E groups, before injury, 
immediately post-injury, and 7 days post-injury; there was not difference in torque 
generating capacity within groups (Table 2). At the remaining frequencies, 20 Hz, and 40Hz, 
no differences are apparent within those groups respectively (Table 2). At 200 Hz pre-injury, 
immediately post-injury, and the 3-day placebo and 20E groups are not different (Table 2). 
The same occurred within the 7-day placebo and 20E groups (Table 2). 
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Table 1. Contractile Function Pre to Post-Injury  
Variable 
 
Pre-Injury  Immediately 
Post-Injury  
Time; Interaction 
P values
 
 
Torque    
   
Torque 1 Hz - 3 
Day (mN/kg) 
   
   Placebo 19.96 ± 5.44 7.650 ± 1.18 0.001 ; 0.249 
   20E 17.41 ± 5.82 4.986 ± 1.26  
    
Torque 1 Hz - 7 
Day (mN/kg) 
   
   Placebo 22.70 ± 5.44 8.400 ± 1.18 0.001 ; 0.249 
   20E 11.54 ± 5.44 7.013 ± 1.18  
    
Torque 20 Hz - 3 
Day (mN/kg) 
   
   Placebo 25.35 ± 3.45 8.838 ± .977 0.000 ; 0.851 
   20E 22.21 ± 3.69 5.929 ± 1.04  
    
Torque 20 Hz - 7 
Day (mN/kg) 
   
   Placebo 28.16 ± 3.46 9.363 ± .977 0.000 ; 0.851 
   20E 28.02 ± 3.46 8.075 ± .977  
    
Torque 40 Hz - 3 
Day (mN/kg) 
   
   Placebo 27.00 ± 3.68 9.775 ± 1.01 0.000 ; 0.843 
   20E 23.32 ± 3.94 6.114 ± 1.08  
    
Torque 40 Hz - 7 
Day (mN/kg) 
   
   Placebo 31.11 ± 3.68 10.84 ± 1.01 0.000 ; 0.843 
   20E 30.22 ± 3.68 8.475 ± 1.01  
    
Torque 200 Hz - 
3 Day (mN/kg) 
   
   Placebo 104.5 ± 8.79 76.90 ± 6.86 0.000 ; 0.207 
   20E 101.9 ± 9.39 64.39 ± 7.33 
 
    
Torque 200 Hz - 
7 Day (mN/kg) 
   
   Placebo 128.2 ± 8.79 65.41 ± 6.86 0.000 ; 0.207 
   20E 124.8 ± 8.79 72.78 ± 6.86 
 
Data are means ± SEM.  20E = 20-Hydroxyecdysone.  
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Table 2. Contractile Function  
Variable 
 
Pre-Injury  Immediately 
Post-Injury  
Harvest Day Time; 
Interaction 
P values
 
 
Torque     
    
Torque 1 Hz - 3 
Day (mN/kg) 
    
   Placebo 19.96 ± 5.44 7.650 ± 1.18 14.53 ± 3.27 0.001 ; 0.317 
   20E 17.41 ± 5.82 4.986 ± 1.26 6.886 ± 3.49  
     
Torque 1 Hz - 7 
Day (mN/kg) 
    
   Placebo 22.70 ± 5.44 8.400 ± 1.18 18.55 ± 3.27 0.001 ; 0.317 
   20E 11.54 ± 5.44 7.013 ± 1.18 12.88 ± 3.27  
     
Torque 20 Hz - 3 
Day (mN/kg) 
    
   Placebo 25.35 ± 3.45 8.838 ± .977 14.78 ± 2.89 0.000 ; 0.910 
   20E 22.21 ± 3.69 5.929 ± 1.04 11.20 ± 3.09  
     
Torque 20 Hz - 7 
Day (mN/kg) 
    
   Placebo 28.16 ± 3.46 9.363 ± .977 20.66 ± 2.89 0.000 ; 0.910 
   20E 28.02 ± 3.46 8.075 ± .977 16.86 ± 2.89  
     
Torque 40 Hz - 3 
Day (mN/kg) 
    
   Placebo 27.00 ± 3.68 9.775 ± 1.01 15.31 ± 2.96 0.000 ; 0.960 
   20E 23.32 ± 3.94 6.114 ± 1.08 11.34 ± 3.17  
     
Torque 40 Hz - 7 
Day (mN/kg) 
    
   Placebo 31.11 ± 3.68 10.84 ± 1.01 22.13 ± 2.96 0.000 ; 0.960 
   20E 30.22 ± 3.68 8.475 ± 1.01 18.94 ± 2.96  
     
Torque 200 Hz - 
3 Day (mN/kg) 
    
   Placebo 104.5 ± 8.79 76.90 ± 6.86 97.58 ± 10.6 0.000 ; 0.022 
   20E 101.9 ± 9.39 64.39 ± 7.33 72.71 ± 11.3 
 
     
Torque 200 Hz - 
7 Day (mN/kg) 
    
   Placebo 128.2 ± 8.79 65.41 ± 6.86 97.40 ± 10.6 0.000 ; 0.022 
   20E 124.8 ± 8.79 72.78 ± 6.86 117.3 ± 10.6 
 
Data are means ± SEM.  20E = 20-Hydroxyecdysone. 
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Protein Synthesis and Signaling  
Markers of protein synthesis and intracellular signaling activity (Akt, 4E-BP1, rpS6) were 
assessed via Western blot analysis and are expressed as arbitrary units (AU). The total 
phosphorylation status of Akt
Ser473
, 4E-BP1
Thr37/46
, rpS6
Ser235/236
 was assessed in the right leg 
(non-contractile leg) for both the tibialis anterior (TA) and extensor digitorum longus (EDL)  
skeletal muscles in groups of n = 8 except for the 3 day 20E group, which had an n = 7.   
 
 
No significant difference was observed in phosphorylation of Akt
Ser473
 in the TA 3 days post-
injury (p = 0.759) or 7 days post-injury (p = 0.128) and EDL 3 days post-injury (p = 0.673) 
Figure 3. Phosphorylated 4E-BP1
Thr37/46
 for the right leg at 3 days post-injury (A) and 
7 days post-injury (B).  
Figure 2. Phosphorylated Akt
Ser473
 for the right leg at 3 days post-injury (A) and 7 days 
post-injury (B). 
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or 7 days post-injury (p = 0.230) (Figure 2A and 2B). In addition, no significant differences  
are observed in phosphorylation of 4E-BP1
Thr37/46
 for the TA 3 days post-injury (p = 0.029) 
or 7 days post-injury (p = 0.842) (Figure 3A and 3B). Furthermore, no significant difference 
was observed in phosphorylation of 4E-BP1
Thr37/46
 for the EDL 3 days post-injury (p = 0.821) 
or 7 days post-injury (p = 0.897) (Figure 3A and 3B). No differences are observed in  
 
 
phosphorylation of rpS6
Ser235/236
 in the TA at 3 days post-injury (p = 0.716) or 7 days post-
injury (p = 0.529) or in the EDL 3 days post-injury (p = 0.574) or 7 days post-injury             
(p = 0.415) (Figures 4A and 4B). Lastly, no significant differences were observed in total 
protein synthesis (puromycin) in the TA 3 days post-injury (p = 0.701) or 7 days post-injury 
(p = 0.190), as well as in the EDL 3 days post-injury (p = 0.797) and 7 days post-injury        
(p = 0.931) (Figures 5A and 5B). Post-injury (p = 0.701) or 7 days post-injury (p = 0.190), as 
well as in the EDL 3 days post-injury (p = 0.797) and 7 days post-injury (p = 0.931) (Figures 
5A and 5B).  
rpS6
Ser235/236
 Figure 4. Phosphorylated for the right leg at 3 days post-injury (A) and 7 
days post-injury (B). 
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Figure 5. Total protein synthesis (puromycin) for the right leg at 3 days post-injury (A) 
 and 7 days post-injury (B).  
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Chapter 5: Discussion 
 The purpose of the current study was to determine the degree to which the 
phytoecdysteroid 20E, (1) enhances recovery of maximal tetanic torque production and (2) 
additively increases protein synthesis after a bout of eccentric contraction muscle injury. This 
study sought to test the hypothesis that 20E would (1) accelerate the rate of recovery of 
muscle maximal tetanic torque production and (2) additively increase the rate of protein 
synthesis after an eccentric contraction muscle injury to the anterior crural muscles compared 
to injured mice not receiving 20E treatment.  
In Vivo Injury Induction 
 At all frequencies (1, 20, 40, 200 Hz) pre-to post-injury there was a significant 
decrease in torque production by the anterior crural muscles. This is consistent with other 
studies that have measured a significant decrease in isometric torque as a function of 
stimulation frequency (22). Corona et al. (22) reported a 52.7% - 92.1% decrease in isometric 
torque after eccentric muscle injury. We report decreases torque production in the 3-day 
placebo group immediately post-injury at 1 Hz, 20 Hz, 40 Hz, and 200 Hz of ~62%, ~65%, 
~63% and ~26% respectively (Figure 6A). Furthermore, decreases in torque production were 
observed in the 3-day 20E group immediately post-injury at 1 Hz, 20 Hz, 40 Hz, and 200 Hz 
of ~72%, ~73%, ~74% and ~37% respectively (Figure 6B). Recovery of torque production 
was still decreased at 3-days post-injury in the placebo group, at the same frequencies, ~27%, 
~42%, ~43%, and ~6% respectively (Figure 6A). Lastly, torque production was still 
decreased at 3-days post-injury in the 20E group at 1 Hz, 20 Hz, 40 Hz, and 200 Hz of ~60%, 
~50%, ~51% and ~29% respectively (Figure 6B). In contrast Corona et al. (22) reported an 
immediately post-injury torque production decrease of ~82%, ~83%, ~81% and ~61% at 1, 
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20, 40 and 200 Hz respectively. At 3-days post-injury, at the same frequencies, Corona et al. 
(22) reported decreases in torque productions of ~82%, ~73%, ~79% and ~70% compared to 
pre-injury values. Our lab did not see the same immediate decrease in toque production in the 
3-day group and our 3-day torque production was still greater than that of what Corona et al. 
(22) reported. In our 7-day placebo group a decrease in torque production was observed 
immediately post-injury by ~63%, ~67%, ~65% and ~49% at 1, 20, 40 and 200 Hz 
respectively (Figure 6A). In the 7-day 20E group, torque production was decreased  
 
 
 
immediately post-injury by ~40%, ~71%, ~72% and ~42% at 1, 20, 40 and 200 Hz 
respectively (Figure 6B). Torque production was still decreased compared to pre-injury 
values at 7-days post-injury in the placebo group by ~18%, ~27%, ~29% and ~24% at 1, 20, 
40 and 200 Hz respectively (Figure 6A). Lastly, in the 7-day 20E group, torque production 
Figure 6.  Isometric torque frequency curve for placebo groups (A) and isometric 
torque frequency curve for 20E groups (B). 
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was increased compared to pre-injury values at 1 Hz by ~12% (Figure 6B). At the 
frequencies 20, 40 and 200 Hz the torque production was still decreased by ~40%, ~37% and 
~6% respectively (Figure 6B).  Corona et al. (22) reported a reduction in torque production at 
7-days post-injury of ~64%, ~60%, ~52% and ~20% at 1, 20, 40 and 200 Hz respectively. 
These comparisons suggest that we saw a slightly more rapid recovery of torque production 
at different time points compared to the data of Corona et al. (22). Warren et al. (67) also 
reported a decrease of about 55% pre to post-injury torque production after eccentric 
contractions. This decrease in isometric torque production is indicative of anterior crural 
muscle injury and not fatigue (67). This study supports the notion that the injury protocol 
induced skeletal muscle injury and not fatigue because of eccentric contractions.  
In Vivo Protein Synthesis, Signaling, and Contractile Function 
 Phytoecdysteroids and their anabolic effects have been well documented (1, 7, 20, 25, 
31, 32, 39, 47, 56, 64). Yet there is still some conflicting results between 20E and increases 
in muscle protein synthesis (20, 47, 64). Some of the conflicting results are differences in 
dosage, administration, and length of treatment. However, the current study is the first to use 
this potentially anabolic agent after an eccentric contraction protocol to assess torque 
production recovery and protein synthesis.  
 To determine if 20E additively increases protein synthesis targets that are thought to 
be phosphorylated after eccentric contractions as well as with the supplementation of 
phytoecdysteroids were assessed. These targets were Akt
Ser473
, 4E-BP1
Thr37/46
, and 
rpS6
Ser235/236
 as well as overall protein synthesis rates via puromycin. To test for activation of 
these signaling molecules the right TA and EDL that were only injured and did not undergo a 
torque-frequency immediately prior to tissue harvest were utilized. We did not detect any 
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differences in activation of either Akt
Ser473
, 4E-BP1
Thr37/46
, or rpS6
Ser235/236
 between 
treatments. 20E has shown to activate the PI3k-Akt pathway (31, 32), but downstream 
mediators of Akt and mTOR such as 4E-BP1 and rpS6 have not all been investigated with 
20E supplementation alone (1).  After eccentric contractions protein synthesis rates have 
been shown to be increased at 3 days post-injury by 30% and at 5 days post-injury by 40% 
(48). The reason for no additional increase in phosphorylation of Akt
Ser473
, 4E-BP1
Thr37/46
, or 
rpS6
Ser235/236
 could be due to having missed the peak of acute signaling since the mice were 
not supplemented the day of tissue harvest. 20E has an eight minute half-life and can be 
eliminated in about 30 minutes (28), which may explain the reason for the missed signaling. 
The current study set out to investigate the chronic signaling effects (days) and not the acute 
signaling effects (hours). Another possible reason could be due to a low dosage amount.  
 We utilized a dosage of 50mg/kg BW of 20E, which has been shown to increase 
protein synthesis, as well as grip strength in rats (32). Anthony et al. (1) suggested that 
dosages of 10, 50, and 200 mg/kg of 20E do not significantly alter the phosphorylation status 
of Akt, mTOR or 4E-BP1 with just gavaging alone. A certain type of stimuli may be needed 
to alter the phosphorylation status of these proteins. Again, in the current study, mice were 
gavaged with 50 mg/kg of 20E, but with the increase in protein synthesis due to the eccentric 
contractions (9, 48) an increased dosage may be warranted to additively increase protein 
synthesis. A limitation of the current study is that no true control non-injured mice were used 
to compare protein synthesis rates. Without the non-injured control mice we are unable to 
determine if the eccentric contractions induced an increase in overall protein synthesis 
without relation to the treatments.  
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We also investigated the torque production capabilities with or without 20E 
supplementation after eccentric muscle injury. When examining the different specific 
frequencies (1, 20, 40, 200 Hz) there was not a consistent significant difference within 
groups. Torque generating capabilities were the same between the placebo and 20E groups at 
3 days post-injury, the same held true for 7 days post-injury. In addition, there were minimal 
differences when investigating other frequencies such as 20, 40, and 200 Hz. The lack of 
consistent differences could be attributed to not having an increased protein synthesis in the 
20E group compared to the placebo group. It has been reported that an increase in mTOR and 
p70s6k1 phosphorylation increases after eccentric contractions and mTOR is important for 
recovery of peak torque (9). Anthony et al. (1) indicated that mTOR was not phosphorylated 
with 20E alone, which could indicate why we did not see any phosphorylation resulting from 
the 20E supplementation.  
Conclusions 
 This study is the first to investigate the effects of 20E on torque production, protein 
synthesis rates and intracellular signaling after eccentric muscle injury. Contrary to my 
hypothesis, 20E does not additively increase protein synthesis or accelerate recovery of 
muscle function after eccentric muscle injury. However, further research is needed to 
determine the appropriate dosage to elicit an additive effect after eccentric muscle injury.  
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